Secukinumab for lamellar ichthyosis in an adolescent: a case report
Lu Li, Fenglei Wei · 2026
Read Secukinumab for lamellar ichthyosis in an adolescent: a case report by Lu Li, Fenglei Wei (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13263478.txt.
Description
Lu Li and Fenglei Wei reported in 2026 a teenager whose inherited scaling skin disorder improved on an immune drug usually aimed at psoriasis. The fourteen-year-old girl had lamellar ichthyosis from birth, with plate-like scales, dryness, and itching over her whole body. Genetic testing confirmed two faulty copies of the TGM1 gene.
Standard treatment with oral acitretin was stopped after it raised her liver enzymes and worsened dryness and itch. Doctors then gave secukinumab, an antibody that blocks the inflammatory signal IL-17, weekly at first and then monthly. Within eight weeks her skin improved substantially, and she stayed on the drug at the time of writing. The authors suggest IL-17 blockade merits formal study in inflammatory forms of this rare disorder.
Catalog record
| CREATOR | Lu Li, Fenglei Wei |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |